Ionis Pharmaceuticals Inc (IONS)

Finanzdaten der Ionis Pharmaceuticals Inc-Aktie (IONS)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	63.18% 119.50	324.50	144.21	188.41	130.52
Cost Of Revenue	29.75% 2.151	3.062	2.191	2.537	1.343
Gross Profit	63.49% 117.35	321.44	142.02	185.87	129.18
Operating Expenses	19.29% 266.86	330.63	285.28	276.07	243.33
Interest Income/Expense	8.93% 4.151	4.558	4.203	2.291	1.608
Benefits Costs and Expenses	20.69% 262.23	330.63	285.01	265.86	243.47
Costs And Expenses	18.64% 269.01	330.63	287.47	278.61	244.67
Operating Income/Loss	2,342% -149.51	-6.122	-143.26	-90.19	-114.15
Income/Loss From Continuing Operations Before Tax	2,231% -142.73	-6.122	-140.81	-77.45	-112.94
Income Tax Expense/Benefit	98.85% 0.075	6.496	6.602	7.842	11.38
Income/Loss From Continuing Operations After Tax	1,442% -142.80	-9.263	-147.41	-85.29	-124.32
Net Income/Loss	1,442% -142.80	-9.263	-147.41	-85.29	-124.32
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	105.36K% 145.54	0.138	143.32	143.10	142.74
Diluted Average Shares	105.36K% 145.54	0.138	143.32	143.10	142.74
Basic Earnings Per Share	1,533% -0.98	-0.06	-1.03	-0.60	-0.87
Diluted Earnings Per Share	1,533% -0.98	-0.06	-1.03	-0.60	-0.87
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-